<SEC-DOCUMENT>0001144204-17-064035.txt : 20171215
<SEC-HEADER>0001144204-17-064035.hdr.sgml : 20171215
<ACCEPTANCE-DATETIME>20171215172053
ACCESSION NUMBER:		0001144204-17-064035
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		4
CONFORMED PERIOD OF REPORT:	20171215
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20171215
DATE AS OF CHANGE:		20171215

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			APPLIED DNA SCIENCES INC
		CENTRAL INDEX KEY:			0000744452
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-MISCELLANEOUS BUSINESS SERVICES [7380]
		IRS NUMBER:				592262718
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0930

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36745
		FILM NUMBER:		171259832

	BUSINESS ADDRESS:	
		STREET 1:		50 HEALTH SCIENCES DRIVE
		CITY:			STONY BROOK
		STATE:			NY
		ZIP:			11790
		BUSINESS PHONE:		631-240-8800

	MAIL ADDRESS:	
		STREET 1:		50 HEALTH SCIENCES DRIVE
		CITY:			STONY BROOK
		STATE:			NY
		ZIP:			11790

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PROHEALTH MEDICAL TECHNOLOGIES INC
		DATE OF NAME CHANGE:	20010504

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	DCC ACQUISITION CORP
		DATE OF NAME CHANGE:	19990211

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	DATALINK CAPITAL CORP/TX/
		DATE OF NAME CHANGE:	19980306
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>tv481513_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0">&nbsp;</P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>UNITED STATES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>SECURITIES AND EXCHANGE COMMISSION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>WASHINGTON, D.C. 20549</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>FORM 8-K</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>CURRENT REPORT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>PURSUANT TO SECTION 13 OR 15(d) OF THE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>SECURITIES EXCHANGE ACT OF 1934</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Date of Report (Date of earliest event reported):
December 15, 2017</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-size: 14pt"><B>Applied DNA
Sciences, Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">(Exact name of registrant as specified in its
charter)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 33%">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Delaware</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">(State or other jurisdiction<BR>
        of incorporation)</P></TD>
    <TD STYLE="width: 34%">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>001-36745</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">(Commission File Number)</P></TD>
    <TD STYLE="width: 33%">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>59-2262718</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">(IRS Employer</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Identification No.)</P></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>50 Health Sciences Drive</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Stony Brook, New York 11790</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">(Address of principal executive offices; zip
code)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Registrant&rsquo;s telephone number, including
area code: <B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>631-240-8800</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>N/A</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">(Former name or former address, if changed since
last report)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Check the appropriate box below if the Form
8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&uml;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&uml;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&uml;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&uml;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&sect;230.405 of this chapter) or Rule 12b-2
of the Securities Exchange Act of 1934 (&sect;240.12b-2 of this chapter). Emerging growth company&nbsp;<FONT STYLE="font-family: Wingdings">&uml;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">If an emerging growth company, indicate by
check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial
accounting standards provided pursuant to Section 13(a) of the Exchange Act.&nbsp;<FONT STYLE="font-family: Wingdings">&uml;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>Item 2.02&nbsp;Results of Operations and Financial Condition.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On December 15, 2017, Applied DNA Sciences, Inc. (&ldquo;Applied
DNA Sciences&rdquo; or the &ldquo;Company&rdquo;) issued a press release announcing its selected preliminary unaudited results
of operations for the fiscal year and quarter ended September 30, 2017. A copy of the press release is furnished as Exhibit 99.1
to this Current Report on Form 8-K.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>Item 8.01 Other Events.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">The information provided in response to Item 2.02 of this Current
Report is incorporated by reference into this Item 8.01.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>Item 9.01. Financial Statements and Exhibits.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">(<I>d) Exhibits</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in; text-align: left"><A HREF="tv481513_ex99-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.1</FONT></A></TD><TD STYLE="text-align: justify"><A HREF="tv481513_ex99-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Press
Release of Applied DNA Sciences, Inc. dated December 15, 2017 regarding preliminary unaudited results of operations for the fiscal
year and quarter ended September 30, 2017.</FONT></A></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>SIGNATURE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 39.65pt">Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned
hereunto duly authorized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date: December 15, 2017</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">APPLIED DNA SCIENCES, INC.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 6%">&nbsp;</TD>
    <TD STYLE="width: 44%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ James A. Hayward</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">James A. Hayward</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>EXHIBIT INDEX</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 12%; border-bottom: black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit No.</B></FONT></TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 86%; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Description</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><A HREF="tv481513_ex99-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.1</FONT></A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="tv481513_ex99-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Press Release of Applied DNA Sciences, Inc. dated December 15, 2017 regarding preliminary unaudited results of operations for the fiscal quarter and year ended September 30, 2017.</FONT></A></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">&nbsp;</P>


<!-- Field: Page; Sequence: 4; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>tv481513_ex99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"><B></B></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin: 0"><B></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><B>Exhibit 99.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><IMG SRC="tv481513_logo.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Applied DNA Announces Selected Preliminary
Unaudited Fiscal Fourth Quarter and Year End Results</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><B>STONY BROOK, N.Y.</B> - December 15,
2017 - Applied DNA Sciences, Inc. (NASDAQ: APDN; &ldquo;Applied DNA) today announced selected preliminary unaudited financial results
for the full fiscal year and quarter ended September 30, 2017.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>Preliminary (Unaudited) Fiscal 2017 Financial Results:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: -0.25in; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Revenues increased 13% to $4.8 million as compared to $4.2 million
in the prior fiscal year. The increase in year-over-year total revenues is attributable to increases in product revenue of approximately
$1.4 million in the textile industry primarily for protecting cotton supply chains, offset by a net decrease in service revenues
from government contract awards of approximately $800 thousand, primarily as a result of two awards which expired in July and August
2016. </FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Total operating expenses were $16.5 million, compared with $15.2 million
in the prior fiscal year, an increase of approximately $1.3 million or 8%. The increase is primarily attributable to an increase
in stock based compensation expense, offset by a decrease in R&amp;D due to the expiration of the two government contract awards.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Net loss for fiscal 2017 was $12.9 million, or $0.49 per share, compared
with a net loss of $12.2 million, or $ 0.51 per share, in the prior fiscal year.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><B>Preliminary (Unaudited) Fiscal Fourth
Quarter Results:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Revenues decreased 30% for the fourth quarter of fiscal 2017 to $1.1
million, compared with $1.6 million reported in the fourth quarter of fiscal 2016, and decreased 36% from the $1.8 million reported
in the third fiscal quarter ended June 30, 2017. The year-over-year quarterly decrease in revenues resulted primarily from decreased
sales to the textile industry. The year-over-year quarterly decrease in textile industry sales was due to the fact that the shipments
of DNA concentrate took place in the third quarter of fiscal 2017 as compared to fiscal 2016 when they took place in the fourth
quarter, as well as the restructuring of payment terms under the June 23, 2017 licensing agreement with Himatsingka America, Inc.
The timing of the shipments is also the reason for the decrease in revenues for the fourth quarter of fiscal 2017 as compared to
the prior fiscal quarter.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Total operating expenses remained fairly flat at $3.7 million for
the fourth fiscal quarter of 2017, compared with $3.6 million in the prior fiscal year&rsquo;s quarter. </FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Net loss for the quarter ended September 30, 2017 was $2.9 million,
or $0.10 per share, compared with a net loss of $2.4 million, or $0.10 per share, for the quarter ended September 30, 2016 and
a net loss of $2.6 million, or $0.10 per share, for the quarter ended June 30, 2017.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white">The Company also announced that it anticipates
filing its Annual Report on Form 10-K for the fiscal year ended September 30, 2017 with the Securities and Exchange Commission
by December 29, 2017.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white">&ldquo;Our fiscal 2017 performance reflects
growing market awareness and adoption of our DNA technology platform in our key business verticals, resulting in the largest pipeline
of pilot projects and highest annual recurring revenue run-rate in Applied DNA&rsquo;s history,&rdquo; stated Dr. James Hayward,
president and CEO. &ldquo;In addition to seeing increasing long-term demand in our textile business, we have broadened the applicability
of our technology platform in markets adjacent to our core markets and are successfully demonstrating to manufacturers that molecular
tag technology can be strategic to their business goals. This is yielding partnerships with market leaders such as Videojet in
inkjet printing and marking systems and Rosier in fertilizer that accelerates our time-to-revenue in their respective verticals.
We believe that our successes in fiscal 2017 place us firmly on a path to revenue growth in fiscal 2018.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white">&nbsp;</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>Preliminary Results</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">The financial data contained in this press release are unaudited,
preliminary, based upon Applied DNA&rsquo;s good faith estimates and subject to completion of Applied DNA's financial closing procedures.
While Applied DNA expects that its final financial results for the fiscal year and quarter ended September 30, 2017, following
the completion of its financial closing procedures, will generally be consistent with the amounts provided in this press release,
Applied DNA's actual results may differ materially from these estimates as a result of the completion of its financial closing
procedures, as well as final adjustments and other developments that may arise between now and the time that its financial results
for the fiscal year and quarter ended September 30, 2017 are finalized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">The results provided in this press release are preliminary and subject
to completion and audit of Applied DNA&rsquo;s financial statements in conjunction with the Company&rsquo;s 2017 Form 10-K filing
with the Securities and Exchange Commission anticipated to occur by December 29, 2017.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>About Applied DNA Sciences </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 30%; font-size: 10pt"><IMG SRC="tv481513_ex99-1img1.jpg" ALT=""></TD>
    <TD STYLE="width: 70%; font-size: 10pt"><FONT STYLE="font-size: 10pt; background-color: white">&nbsp;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">Applied DNA Sciences makes life real and safe by providing innovative, molecular-based technology solutions and services that can help protect products, brands, entire supply chains, and intellectual property of companies, governments and consumers from theft, counterfeiting, fraud and diversion. The proprietary DNA-based &ldquo;CertainT<SUP>TM</SUP>&rdquo; Platform can be used to identify, tag, track, and trace products, to help assure authenticity, origin, traceability and quality of products. SigNature&reg; DNA describes the core technology ingredient that is at the heart of a family of uncopyable, security and authentication solutions such as SigNature&reg; T and fiberTyping&reg;, targeted toward textiles and apparel, BackTrac&trade; and DNAnet&reg;, for anti-theft and loss prevention, and digitalDNA&reg;, providing powerful track- and-trace. All provide a forensic chain of evidence, and can be used to prosecute perpetrators. Applied DNA Sciences is also engaged in the large-scale production of specific DNA sequences using the polymerase chain reaction.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Go to&nbsp;adnas.com&nbsp;for more information, events and to learn
more about how Applied DNA Sciences makes life real and safe.&nbsp;Applied DNA&rsquo;s Common stock is quoted on NASDAQ under the
symbol APDN, and its warrants are quoted under the symbol APDNW.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>Forward-Looking Statements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="background-color: white">The statements made by APDN
in this press release may be &ldquo;forward-looking&rdquo; in nature within the meaning of the Private Securities Litigation Act
of 1995. Forward-looking statements describe APDN&rsquo;s future plans, projections, strategies and expectations, and are based
on assumptions and involve a number of risks and uncertainties, many of which are beyond the control of APDN. Actual results could
differ materially from those projected due to our history of losses, limited financial resources, limited market acceptance, market
competition and various other factors detailed from time to time in APDN&rsquo;s SEC reports and filings, including our Annual
Report on Form 10-K filed on December 6, 2016, and our subsequent quarterly reports on Form 10-Q filed on February 9, 2017, May
11, 2017 and August 10, 2017 &nbsp;which are available at&nbsp;<U>www.sec.gov</U>. APDN undertakes no obligation to update publicly
any forward-looking statements to reflect new information, events or circumstances after the date hereof to reflect the occurrence
of unanticipated events, unless otherwise required by law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B><IMG SRC="tv481513_logo.jpg" ALT=""></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>Investor contact: </B>Sanjay M. Hurry, 212-838-3777, LHA, <B>shurry@lhai.com</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>Media contact: </B>Susan Forman, Dian Griesel Int&rsquo;l., 212-825-3210,
<B>sforman@dgicomm.com</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>Web: </B>www.adnas.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>Twitter: </B>@APDN</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>tv481513_ex99-1img1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tv481513_ex99-1img1.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ M "U P$1  (1 0,1 ?_$ ,P    & P$! 0
M       &!P@)"@$$!0(#"P$!   ' 0$               (#! 4&!P@!"1
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MSM61[>C#\G\76+C-:;Y9JY%,HB.R+B#*>2*F:*N\7&>4=JVB+95GKV)DBH$
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M<X=%^H!]/42E!H3-9B(1^:2D4E!P(FV133(F1-)) @$2(0I4TT4RAVE*F4
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M9&WL)W6XAF&YO7*&5^U0'[H<1(\:<1Y9F9*\U_(EF=4'(-D@+S>J53K)%O\
M&^1K#"DC_M4Q)BW;/7J!#J0[0SM-H[22=@@7S"CUWPU>7R^(*;>^9*;FW2I
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M"T4>IKRU#QY,Y2L[M\TC8>L0\A&1"9W,@J"9)"9G9-4K6(@&F_F.G7:LHFD
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M(YMR)7Z)(F@;I>,?5F+F8F"FTFS=V[C&\0O.LK185HUH[2.Y,Q:+E3!3IW"
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M 'M*]=V)X3?<H)0R!"M1'YE^Z.T.GX#I"#<Y1[B)E W:(*"8IA+W;&V,("(
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M@ &$A*[ )I:1Z>2IE=M& IT[=T:RZC1-W?+SUP3WW\>FID0P9E$21^16;T"
M4UE@G4:X.'3N<0*A'C'<=]A,9N\<_N)I"%!TA TA$5?O%827S;P5RXVBVAWD
M_CK[9D^$22'<YEZHN9652  W-]<$X<[AK;G87D9PG=6Q0I02R[)!),@-T^NF
MH K&K^[F#1F>*.N+$U,IF/=%"O?N+W!^7;NW^ !\Q_#7U&8;]15P\U-86H'R
MUZGPCYT-J0A#R72$J2Y( F1U/C&/^W]P^ _L'4)\IDJA]L!43&D9Z[?CJ;:>
MJR^MQW_NJQ*)=PPU=-)2BCR3.>@]E8EEX ^Z]=^$].G,16#'4;F'#\Y*OII*
MMN9(L9+P4A+-2-9M-FL[;NHY]$3)TP,HU7(<I1W[3;"(:YK[L]@K+FV2_P P
MX9WT<P@@@F9$P=?*G=N -)&-X<"[OY?A]B,1<MIN,>:$'277^("OMAV=U]\V
MM5''E@I?$'BA6\$SEE2<J/+,9>"0:QCQXB=->4:P-9C&K>3E$"J#Z<SA3M3$
M=]M8-8?3/G?ZBQD>X^1+V+1+TPC<5>($BE4@>M 3&79WZ@BO'*LNWM@EO)K_
M )A(D/ D'<*^%3$?/ +W#KWP?RQ=KR>"-DNLY1(8V18!S)?:Y:6E0?N))"Q1
MD@=)9NTFB.WJQ!(I_)4!00-ML&MO=R^QV.Y_@+?"V-VM.:8: ME*!V!KHE7D
MTU,@08U_PGNSG>%9M6<RELU_3'?YZ9B9<-5* WZR]D2%6#WWH&NY(;7/!G$*
METPDI)K2.5I23=P;:[Y)\QHX318KS]?B#A'D0D5$5EE51<++'3#Z.HCK3^-^
ME?,OXQW#\CRH=NFVR+9*2I3:5BHW@)493I24AX1L3*?419B]&8XOCT-^H1ZR
MB)%29UD=PK+[3$7///F '-K.+7.2N/"8WD4ZG7ZQ)PZ-@-8T7PU]=V9I)(KJ
MQL:=N55!V5,0\L1W(&MZ]JNV?(.$<1:P5RXA3JKQZJ= "I(C3?</G#?,.2O9
MIL;4"S9('N2KQ.OC[8=9S%]VR8Y:\8H3C:[PBRHK2$>4=XE;$;HK/*N1I##T
M8)&B30#,B O^AAV6-Y/AUWWUKG@78[,\3[@W/-[UQI5N+MY24I!W5=403\/"
M,]Y3W;8Y#QJRXF$2(LVPH]#)M(\81CV^_<DR;P+G;(VA*XPR)C2\.$)"S41_
M)*1JZ4LU0%NC-5^531=$;/@:F\M4JB2B2J8!OL/AGG>;LXUW<*,M9*2SDFF]
MJ5*D ::*ZD>ZL8[VS[K/<#OE85:5&R6KP,O?/2<2,6[WXJG6*?;HSC!Q'@<.
M72[>?(2]J=/JXFW1GGR)DSV!>*K,:W/-2:&XG2%P8H;]?GOI"Q^E[ECV28>[
M@7@58,@;1NFHI$MHF=PVR^,HV=E?J+X[;6CEKP.W]-Y9.XD$>8_,>G6<5W9B
M7D[!*RD_-OG$G-3LB]F9:0=*&5</I&3=+OGKY50XF-WNG+@QMM]@UV/B,,S@
ML"QBK$?X)L^7[(YDR>1N,SEG<O?_ /?714_&<<W\?@ @ _@(^ #^(_#50H%(
MFJ@]M(I_;T@?^';]_P OVZ\I('H=/;[H @Z5E^W3[84#$^/)?+>4\=XL@6YG
M4S?[I7JHT0(&Y@^[2:#=RL<NPCY35H*BA_\ A(.L=Y9EA@^-W>54H)0VPHS)
MD)$'K[>GCTB_\:QRLGG+>RVJ45+T )/EJ:>SKX1^EI0JRQI5-JU/BTQ3C*K7
M8.N1Z8_P,H6,:QK8H!X!L@V+O^.OD/?7:[_-75TO5;A5\5$F/IK@K--GA;>V
M_P!%H#[H.@!L&W[=4S<]M?$Q<Y 4$ 1 H"8?  $1_8 ;CJ.$)!]F;_H@77<7
M;]1!<A5[AW!O^IC2I5_'Q&/W'??\-(09KLFJVC6,XB3=>M2K*5.?Q,9AYGI)
M<A0*/0%8UPH)OP#2$'1%4JI0.42B4Y04*8O@8IS'[# /Q[B%#2$?;2$<2:AF
M$]%2L'+-4'D3-,GD;),EB]R3MB_;J-7:"P?Q)KMU3%,'Q =>LOILWDO6]+C<
M#3Q%9Q1WMLF_MU6UT ;<B1]VD5J,\>T=P$G+2A1J5:LE<:\D6*WV&F5!%^=S
M;Z-/3L)7$[8D8 F0="PC'\(HJJB8KU!17REB@'>3;73?#^_W<_C]HG]$0[9-
MI&Z6X*"=#3=(_9'._).RO;G)7*GKP!%PHTF!*?\ T9C[X@UY9^W=R(XBMTK3
M:XEA?,120)J0>9L>*+3E*?ME]S-UI15,%'-?56)L( Y_E&'?L4-MKJO@?>[B
MG.&TV5\?3Y$:%*Z*!^(K7P)CG3F7:7D_%7#>V8WX 5&W27V^'LAC"2:BZJ;=
M!-1PX661;-6[8AG#AVX<& J#=H@B4ZKI98Q@ A" 83=P;;[ZVJ_ZMDA7]==1
M;X5(FE\D25.ID9UD:?"-9L+;N'@JW:5<H49>@ 24D4-)=372)G^*?LR9;RM$
MPF1^25L9\;<9R;B/+&Q\LBDKDVP#,+IH1B36!7,FVKZ<HJ<I&X/3**J*"  G
MN(!KF7N!]0MMQUY_#<$<-W>E)";A$Y-*\=U)D2.AH(Z$X=V7N.0VJ,SD1^@P
MZ9%QA5"XCJ-OWU$HDWJ'!+VJ:,:/@SXLN^5EG:U):'M]\M<RT9N"9";2C2J3
MJC9L\AV;&,E+C#J03A0[<!CI$Z::@ 40$=(7?<SO5E'U/.9-YI](4H)22=SJ
M2-S521,-'U0G4B9 ,;?M>WW;G&,A@!)MJ)*R4B3.H>H)R+GY4])TA';5P4]L
M/.D;CUA3QRAQ2R+D^P6S'<**[Q[8*Q6,R4M=1G-8MNS*;>R,>PMFY 79D!=J
MG(HF*HB=03 &L@QO=KO-@E7%Z;M=_A\:EMYX[O,IAQ0 6W)5=Q.TR2HRG.0T
MQZY[6=L.0#9D$AN\71*3+RK\#Y:&(8N9/M_9ZX23B9<B1;2PXYE7JK2L9;J@
M+N:A)JIJ^6FT?'$JIZ[8# ( 9HZV[C"8$C&[=]=,]O\ NQQ7N8VFRX:T,5S2
M\!<<01L"&T>=01,(FJX3-"@%$E)J)1H'FG;'DG!;E3G(CNX@3^214)'\*J%4
MI>X0AV N/.7N3>0(_&V&:@_M-E<=CAVNFD*<+6&('[5IFSRJI#,HB-:?QF4W
M,([%*0QA -9ARGF^)X/C%O\ (+M-G=)29-3J3_H@"9F=-(Q_CO%[[DUZAG 6
MJKNR6?YH% /&9E%@'&OM<\)>.%GQM3.6%RL.>LN7J"G+P]J]'D%X7%^.Z!56
MRCJUWFWR39VC)EJL1Y9DR.W3E/U3@O8DB/PY'SG>[N)RJWN;GBC?Z'%VRD@O
M'^<XM<_32A.X;BHTDD*(GYI1TCA^U7#^+>DKD>V]N[DU2)$6Z$_S%$R,I3F=
M)RI"_1^'_;$N5)92+CA&UKD3,UM2U1OVZ5D(^W'JD_;V=*Q ^6]&_;/6]@S!
M**'<QK-10%DV"8JJ&$!VU@(Y?W?9N5)M,]<7:DJ$@X?*H;2M_P#F&4F%#TU'
MQH#6,NN,+VSNV E6* 44DD;?E4D[64_+J\C\P>(AMN;?9=P;E%K+3G";,#B
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M6^.J!BMLOBRN\?<RR-I;PV9[!;']>C#VU5-<B*RZ,>ZGG1T@$X$3,0QA52*
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M)Q-VCL !T^6I#5A8VYFPPR@SGY4)37QH!7VQ-7<7#HDZXXH2 JHF@H!4Z 4
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EGV>5V>5V[#_N]>SY[_'2$;>D(&D(&D(&D(&D(&D(&D(&D(__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>tv481513_logo.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tv481513_logo.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ *0$, P$1  (1 0,1 ?_$ +0  0 " @(# 0$
M       '"08(! H! P4""P$!  (# 0$!              8' 0(%! ,($
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M7PBX02#071F/S+?YXJ?O&8@X1%X5 1 "K"V[_>!(PC^(0Z<(N4<X$*)A]"@
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M?V%9G&IA*8D?:J^@9C+1,DAVN&QSD2< F?M5(4Q1Y:V*_E&7T!K;/A%HFR6
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6KVP^ _U_]8<+5?OA$X1.$3A$X1?_V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
